Back to search

Article

Predictive Performance and Clinical Application of COV50, A Urinary Proteomic Biomarker in Early COVID-19 Infection: A Cohort Study

2022-01-25

Abstract excerpt

Background: The SARS‑CoV‑2 pandemic remains a worldwide challenge. The CRIT‑Cov‑U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression. Following the interim analysis demanded by the German government, the full dataset was analysed to consolidate findings and propose clinical applications. <br><br>Methods: In eight European countries...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
56124ffd-7de5-521f-8eff-7fb14ed04e27
DOI
10.2139/ssrn.4006139
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predictive Performance and Clinical Application of COV50, A Urinary Proteomic Biomarker in Early COVID-19 Infection: A Cohort StudyDOI 10.2139/ssrn.4006139
Select a neighboring publication to make it the new centre.